CHARMY PATEL: Open Payments
NPI 1013451921 · DRACUT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 19 payments from 12 companies in 2025. Trend: 2023 $525 · 2024 $274 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $132 |
| Lilly USA, LLC | 4 | $91 |
| Tandem Diabetes Care, Inc. | 3 | $53 |
| Novo Nordisk Inc | 2 | $45 |
| Medtronic, Inc. | 2 | $41 |
| CeQur Corporation | 1 | $35 |
| Insulet Corporation | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
Products named: DEXCOM G7 GSS (161), JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, MINIMED 780G, CeQur Simplicity, OMNIPOD, Kerendia.
Industry payments across MA — which companies pay providers there.
